Multi-Center, Double-Blind, Randomized Study to Investigate the Impact of a Sequential Oral Contraceptive Containing Estradiol Valerate and Dienogest (SH T00658ID) Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (Microgynon) Over 6 Treatment Cycles on Alleviating Complaints of Reduced Libido in Women With Acquired Female Sexual Dysfunction (FSD) Associated With Oral Contraceptive Use.
Phase of Trial: Phase III
Latest Information Update: 26 Aug 2014
At a glance
- Drugs Estradiol valerate/dienogest (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Pregnancy
- Focus Adverse reactions
- Sponsors Bayer
- 02 Aug 2010 Actual end date (July 2010) added as reported by ClinicalTrials.gov.
- 02 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.